Reliability and validity study of the Turkish version of the Schizophrenia Cognition Rating Scale (SCoRS-TR)

IF 3.8 4区医学 Q1 PSYCHIATRY

Asian journal of psychiatry Pub Date : 2024-10-31 DOI:10.1016/j.ajp.2024.104301

Nedim Özak , Emine Ilgın Hoşgelen , Berna Binnur Akdede , Köksal Alptekin

{"title":"Reliability and validity study of the Turkish version of the Schizophrenia Cognition Rating Scale (SCoRS-TR)","authors":"Nedim Özak , Emine Ilgın Hoşgelen , Berna Binnur Akdede , Köksal Alptekin","doi":"10.1016/j.ajp.2024.104301","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Schizophrenia is characterized by significant dysfunction in cognitive domains. Despite its crucial role in prognosis, evaluating neurocognitive impairments is challenging in outpatient settings because of the time-consuming nature of neurocognitive assessments. SCoRS “Schizophrenia Cognition Rating Scale” is a scale that provides brief cognitive evaluation. This study aimed to establish the validity and reliability of the Turkish version of the “Schizophrenia Cognition Rating Scale” (SCoRS-TR) in patients with schizophrenia and examine the correlation between SCoRS and cognitive tests.</div></div><div><h3>Methods</h3><div>Data were collected from 130 patients with schizophrenia who met the DSM-5 criteria and 40 healthy controls. SCoRS rating, Positive and Negative Syndrome Scale (PANSS), and a neurocognitive test battery were administered.</div></div><div><h3>Results</h3><div>Findings indicated that SCoRS-TR is a reliable and valid scale for the Turkish population. The scale demonstrated strong internal consistency, with Cronbach's alpha values ranging from 0.937 to 0.940. High interrater reliability (ranging from 0.90 to 0.98) and test-retest reliability (ranging from 0.976 to 0.990) were observed. SCoRS-TR significantly discriminated patients from healthy controls (p<0.001). SCoRS-TR exhibited significant correlations to neurocognitive tests.</div></div><div><h3>Discussion</h3><div>Results indicated that SCoRS-TR had significant reliability and validity scores that may be useful for evaluating daily life functioning related to cognitive dysfunction in patients with schizophrenia. This approach may be useful for neurocognitive evaluation and monitoring in clinical follow-up and outpatient settings.</div></div>","PeriodicalId":8543,"journal":{"name":"Asian journal of psychiatry","volume":"102 ","pages":"Article 104301"},"PeriodicalIF":3.8000,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian journal of psychiatry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1876201824003940","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}

引用次数: 0

Abstract

Background

Schizophrenia is characterized by significant dysfunction in cognitive domains. Despite its crucial role in prognosis, evaluating neurocognitive impairments is challenging in outpatient settings because of the time-consuming nature of neurocognitive assessments. SCoRS “Schizophrenia Cognition Rating Scale” is a scale that provides brief cognitive evaluation. This study aimed to establish the validity and reliability of the Turkish version of the “Schizophrenia Cognition Rating Scale” (SCoRS-TR) in patients with schizophrenia and examine the correlation between SCoRS and cognitive tests.

Methods

Data were collected from 130 patients with schizophrenia who met the DSM-5 criteria and 40 healthy controls. SCoRS rating, Positive and Negative Syndrome Scale (PANSS), and a neurocognitive test battery were administered.

Results

Findings indicated that SCoRS-TR is a reliable and valid scale for the Turkish population. The scale demonstrated strong internal consistency, with Cronbach's alpha values ranging from 0.937 to 0.940. High interrater reliability (ranging from 0.90 to 0.98) and test-retest reliability (ranging from 0.976 to 0.990) were observed. SCoRS-TR significantly discriminated patients from healthy controls (p<0.001). SCoRS-TR exhibited significant correlations to neurocognitive tests.

Discussion

Results indicated that SCoRS-TR had significant reliability and validity scores that may be useful for evaluating daily life functioning related to cognitive dysfunction in patients with schizophrenia. This approach may be useful for neurocognitive evaluation and monitoring in clinical follow-up and outpatient settings.

查看原文本刊更多论文

土耳其版精神分裂症认知评定量表（SCoRS-TR）的可靠性和有效性研究。

背景：精神分裂症的特点是认知功能严重障碍。尽管神经认知障碍在预后中起着至关重要的作用，但由于神经认知评估耗时较长，因此在门诊环境中评估神经认知障碍具有挑战性。SCoRS "精神分裂症认知评定量表 "是一种提供简短认知评估的量表。本研究旨在确定土耳其版 "精神分裂症认知评定量表"（SCoRS-TR）在精神分裂症患者中的有效性和可靠性，并研究 SCoRS 与认知测试之间的相关性：收集了 130 名符合 DSM-5 标准的精神分裂症患者和 40 名健康对照者的数据。方法：收集 130 名符合 DSM-5 标准的精神分裂症患者和 40 名健康对照者的数据，并进行 SCoRS 评分、阳性与阴性综合征量表（PANSS）和神经认知测试：结果：研究结果表明，SCoRS-TR 对土耳其人来说是一个可靠、有效的量表。该量表具有很强的内部一致性，Cronbach's alpha 值在 0.937 至 0.940 之间。研究人员之间的信度（从 0.90 到 0.98）和测试再测信度（从 0.976 到 0.990）都很高。SCoRS-TR 能明显区分患者和健康对照组（p 讨论：结果表明，SCoRS-TR 具有显著的信度和效度，可用于评估精神分裂症患者与认知功能障碍相关的日常生活功能。这种方法可用于临床随访和门诊环境中的神经认知评估和监测。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Asian journal of psychiatry Medicine-Psychiatry and Mental Health

CiteScore

12.70

自引率

5.30%

发文量

297

审稿时长

35 days

期刊介绍： The Asian Journal of Psychiatry serves as a comprehensive resource for psychiatrists, mental health clinicians, neurologists, physicians, mental health students, and policymakers. Its goal is to facilitate the exchange of research findings and clinical practices between Asia and the global community. The journal focuses on psychiatric research relevant to Asia, covering preclinical, clinical, service system, and policy development topics. It also highlights the socio-cultural diversity of the region in relation to mental health.